Hip disorders including osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who are indicated for a primary THA, and entered this study on the basis of their agreement to participate in the clinical trial. Patients who are indicated for this surgery on both sides can be included. 2) Patients who have an indication for the Aquala liner with a femoral head of 28 mm or 32 mm in diameter. 3) Patients aged 75 or younger at the time of a written prior consent to participate in this clinical study(no gender selective).
Exclusion criteria
Exclusion criteria: 1) Patients who are not indicated for a primary THA 2) Patients with unstable clinical conditions 3) Patients whose weight is over the weight restriction of the femoral components to be used 4) Patients who are difficult to be followed for 5 years after the index surgery 5) Patients who are unable to evaluate their own QOL 6) Patients whose functions of the hip joints are difficult to evaluate due to disorders of other organs such as heart and nervous system 7) Patients who once had an artificial hip joint in the same hip joint 8) Patients who are at high risk of thrombosis or bleeding 9) Patients susceptive to infection 10)Patients receiving the anticancer drug therapy 11)Patients who are evaluated to be unsuitable for the subject of this study by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wear of the polyethylene liner | — |
Countries
Japan
Contacts
Graduate School of Medicine, The University of Tokyo Div. Science for Joint Reconstruction